期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 13, 期 10, 页码 1237-1248出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.13.10.1237
关键词
A-304121; ABT-239; Alzheimer's disease; attention deficit hyperactivity disorder; cipralisant; cognition; cognitive domains; FUB-181; GT-2331; H-3 receptors; histamine; learning; memory; schizophrenia
Histamine H-3 receptor agonists and antagonists have been evaluated in numerous in vitro and in vivo animal models to better understand how H-3 receptors modulate neurotransmitter function in the central nervous system. Likewise, behavioural models have explored the hypothesis that changes in neurotransmitter release could enhance cognitive function in human diseases. This review examines the reported effects of H-3 receptor ligands and how they influence cognitive behaviour. These data are interpreted on the basis of different cognitive domains that are relevant to neuropsychiatric diseases. Because of the diversity of H-3 receptors, their function and their influence on neurotransmitter systems, considerable promise exists for H-3 ligands to treat diseases in which aspects of learning and memory are impaired. However, because of the complexities of the histaminergic system and H-3 receptors and the lack of clinical data so far, proof of principle for use in human disease remains to be established.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据